Form 8-K - Current report:
SEC Accession No. 0000950170-25-084650
Filing Date
2025-06-11
Accepted
2025-06-11 07:15:25
Documents
10
Period of Report
2025-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20250606.htm   iXBRL 8-K 47770
  Complete submission text file 0000950170-25-084650.txt   155177

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20250606.xsd EX-101.SCH 25787
12 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20250606_htm.xml XML 4709
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 251038769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)